Two-center cohort study demonstrates feasible occlusion and low complication rates for recurrent aneurysms, indicating the Woven EndoBridge device is a viable salvage option.
BACKGROUND: The safety and efficacy of the Woven EndoBridge (WEB) for the treatment of naïve intracranial aneurysms has been confirmed. PURPOSE: To analyze the safety and efficacy of the WEB in the treatment of recurrent aneurysms. METHODS: Anatomical and clinical results in consecutive patients with a recurrent aneurysm, who were treated using the WEB device in two French neurointerventional centers, were evaluated. RESULTS: Seventeen patients with 17 aneurysms were included. Treatment was feasible in 16 patients. In seven patients (41.2%), ancillary devices were used. Permanent morbidity due to a thromboembolic complication occurred in one patient (5.9%). There was no mortality. Follow-up angiographic studies were available for 15 patients after a mean of 12.1±6.1 months. Rates of complete occlusion, neck remnant, and aneurysm remnant were 33.3%, 40.0%, and 26.7%, respectively. CONCLUSIONS: Treatment of recurrent aneurysms using the WEB device may be reasonably safe and effective.
No takes yet. Share an insight, caveat, or question.
Gawlitza et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: